Related Experiment Video
Updated: Dec 25, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Association between sarcoidosis and cardiovascular comorbidity: A systematic review and meta-analysis
Abdalla Reda Mahmoud1, Abdullah Dahy1, Mahmoud Dibas2
1Faculty of Medicine, Minia University, Minia, Egypt.
Insights
This study found that sarcoidosis is linked to increased risks of heart failure and hypertension. Early diagnosis and management of cardiovascular issues in sarcoidosis patients are crucial for better outcomes.
Area of Science:
- Cardiology
- Pulmonology
- Systematic Review
Background:
- Cardiovascular involvement in sarcoidosis significantly impacts patient morbidity and mortality.
- Effective management strategies are essential for patients with cardiac sarcoidosis.
Purpose of the Study:
- To determine the prevalence of cardiovascular comorbidities in sarcoidosis patients.
- To analyze the association between sarcoidosis and various cardiovascular conditions.
Main Methods:
- A systematic review and meta-analysis of 14 studies.
- Electronic searches across nine databases.
- Quality assessment using the National Institute of Health tool.
Main Results:
- Hypertension (28.8%), heart failure (9.3%), and arrhythmia (8.1%) were the most common comorbidities.
- Sarcoidosis showed a significant association with heart failure (OR=2.10) and hypertension (OR=1.27).
- No significant association was found with cerebrovascular disease, ischemic heart disease, or ventricular tachycardia.
Conclusions:
- Sarcoidosis is associated with specific cardiovascular comorbidities, notably heart failure and hypertension.
- Prompt diagnosis and aggressive management are vital to mitigate risks in affected individuals.
Background:
Sarcoidosis with cardiovascular involvement is critical and is associated with morbidity and mortality of the affected patients, if not properly managed. In this systematic review and meta-analysis, we aimed to review the available literature to find the prevalence of cardiovascular comorbidities and their association with sarcoidosis.
Methods:
An electronic search was conducted through nine databases for articles reporting cardiovascular comorbidities in sarcoidosis patients. We assessed the quality of each included article using the National Institute of Health quality assessment tool (NIH), while meta-analysis was used to pool the results.
Results:
Out of 2208 reports screened, we included 14 studies. The most common cardiovascular comorbidities were hypertension 28.8%, heart failure 9.3% and non-specified arrhythmia 8.1%. There were significant association between sarcoidosis and heart failure and hypertension rather than controls (OR = 2.10, 95%CI (1.65 - 2.69), p < 0.01) and (OR = 1.27, 95%CI (1.02 - 1.59), p = 0.036), respectively. However, we found no association between sarcoidosis and cerebrovascular disease, ischemic heart disease and ventricular tachycardia (p > 0.05).
Conclusion:
Sarcoidosis is associated with certain types of cardiovascular comorbidities. Timely diagnosis and aggressive management in this population are needed to minimize the hazards associated with the disease.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy I: Introduction and Classification
Rheumatic Heart Disease I: Introduction